Moderna CFO Meline steps down $42 million richer, passing reins to incoming finance chief Gomeznews2022-04-11T20:25:32+00:00April 11th, 2022|Fierce Pharma|
High-flying Pfizer may disappoint on Comirnaty and Paxlovid sales in Q1, analyst warnsnews2022-04-11T17:44:06+00:00April 11th, 2022|Fierce Pharma|
Lilly goes down under to find a partner for failed cancer drug Lartruvo, licensing certain rights to Telix for $5Mnews2022-04-11T15:07:29+00:00April 11th, 2022|Fierce Pharma|
Pfizer signals big M&A plans with new CFO Denton, the money manager behind the CVS-Aetna mergernews2022-04-11T14:34:34+00:00April 11th, 2022|Fierce Pharma|
Moderna recalls vaccine batch after foreign substance found in CDMO-made vial—againnews2022-04-11T14:03:50+00:00April 11th, 2022|Fierce Pharma|
Insomnia drug maker Idorsia amps up awareness push with eye-opening Alliance for Sleep surveynews2022-04-11T13:32:07+00:00April 11th, 2022|Fierce Pharma|
Seagen scores $41.8M in Enhertu patent case against Daiichi Sankyonews2022-04-11T13:31:29+00:00April 11th, 2022|Fierce Pharma|
GlaxoSmithKline, CureVac and BioNTech clinch German pandemic preparedness contractsnews2022-04-11T12:37:42+00:00April 11th, 2022|Fierce Pharma|
AACR: Bristol Myers details Opdivo’s presurgery lung cancer win, with an early sign of survival benefitnews2022-04-11T10:15:28+00:00April 11th, 2022|Fierce Pharma|
AACR: 2 years in, Amgen fortifies Lumakras lung cancer data fortress for upcoming Mirati, Novartis KRAS battlenews2022-04-09T14:00:14+00:00April 9th, 2022|Fierce Pharma|
